MEA Magazine
  • Home
  • MEA Events
  • Business News
  • Financial News
  • International News
  • Companies To Watch
  • Government News
  • Auto Industry
  • About MEA
    • Testimonial
  • MEA Resource Guide
  • MEA Events
News Ticker
  • [ October 30, 2023 ] 5 Tips to Get Ahead of Holiday Debt Financial Literacy
  • [ October 7, 2025 ] Israel’s Post-October 7 Art Scene By Art Up Nation On Display In NYC World
  • [ October 7, 2025 ] Why Market-Driven Adoption is Crucial for Sustainable Technology World
  • [ October 7, 2025 ] Why Market-Driven Adoption is Crucial for Sustainable Technology Business
  • [ October 7, 2025 ] Lessons for the US in Canada’s Solar Energy Failure Business
  • [ October 7, 2025 ] Researcher Cultivates Ruby In A Ring, Pioneering Sustainable Gemstone Growth‌ World
  • [ September 23, 2024 ] AI Skills Top Priority In Israel’s High-Tech Sector Amid Conflict ‌ Middle East
  • [ September 23, 2024 ] Novel Antibody May Be Key To Better Lung Cancer Treatment Middle East
  • [ September 23, 2024 ] “Germany Struggles To Find Reliable Alternatives To Fossil Fuels” – Former Top EU Energy Policy Official  Energy
  • [ September 17, 2024 ] Medical Doctor Develops Generative AI Financial Tools For Gen Z And Millennials crypto
  • [ September 16, 2024 ] Israel Ranks Fourth In Global AI Landscape, Attracts Top Talent‌ Technology
HomeCures & Breakthroughs

Cures & Breakthroughs

Boxes of the diabetes drug Ozempic rest on a pharmacy counter in April 2023 in Los Angeles, California. Ozempic was originally approved by the FDA to treat people with Type 2 diabetes-who risk serious health consequences without medication. In recent months, there has been a spike in demand for Ozempic, or semaglutide, due to its weight loss benefits, which has led to shortages. Some doctors prescribe Ozempic off-label to treat obesity. MARIO TAMA/GETTY IMAGES.

Big Pharma’s Monopoly On Ozempic Threatens Access To Diabetes Drug In Communities Of Color

Small pharmacies find difficulty in prescribing the drug due to Big Pharma restrictions on the industry.
‌ […]

strongA recent study indicated that artificial intelligence performed on par with human doctors in interpreting screens, suggesting that it may soon be used in diagnosing breast cancer. ANGIOLA HARRY/UNSPLASH/strong

AI Could Soon Be Used To Help Detect Breast Cancer

AI performed on par with human doctors in interpreting screens, suggesting that it may soon be used in diagnosing breast cancer. […]

strongCurespec’s Nephrospec device. The Israeli company Curespec, situated in Yehud-Monosson, says that its novel product, Nephrospec, can delay the dialysis regimen for CKD patients in stages three and four by up to 12 months. CURESPEC/strong

Startup Aiming To Keep Kidney Patients Off Dialysis

The use of electro-hydraulic acoustic therapy can stop the progression of late-stage chronic renal disease by up to a year. […]

strongAfter identifying several kinds of Parkinson's disease using artificial intelligence, personalized treatment is possible. Four illness subtypes were correctly identified by the team, with one reaching a classification accuracy of 95%. PIXABAY/PIXELS/strong

Personalized Treatment For Parkinson’s Disease On The Horizon Thanks To AI

The breakthrough could pave the way for personalized medicine and targeted drug discovery. […]

SpaceX CEO Elon Musk arrives at the Red Bull Racing's garage before the third practice and qualifying sessions for the 2023 Miami Formula One Grand Prix at the Miami International Autodrome in Miami Gardens, Florida, on May 6, 2023. (CHANDAN KHANNA/GETTY IMAGES)

Elon Musk-Backed Brain Chip Company Neuralink Gets $280 Million In Funding

Neuralink receives approval from the FDA for human experiment trials as experimentation looms. […]

Joanie Melady serving with her Koalaa prosthetic. (Koalaa via SWNS)

9-Year-Old Tennis Star Triumphs With New Prosthetic Arm

Joanie Melady wins doubles tournament after receiving innovative Koalaa prosthetic enhancement.
The post 9-Year-Old Tennis Star Triumphs With New Prosthetic Arm appeared first on Zenger News.
[…]

Interview with Richard T. Benson, M.D.,a Ph.D. Director, Office of Global Health and Health Disparities National Institute of Neurological Disorders and Stroke

Roy Hargrove & Mulgrew Miller “In Harmony” (Mini-Documentary)

Archives

Roy Hargrove & Mulgrew Miller “In Harmony” (Mini-Documentary)

Archives

Contact us
MEA Magazine P.O. Box 173 Woodbridge, Virginia 22194 Tel. (703) 730-4091 Fax (703) 730-4092 E-mail: dwilliams@meamagazine.com
All Rights reserved MEA Magazine 2015
Site Design CB & Associates
MEA Magazine P.O. Box 173 Woodbridge, Virginia 22194 Tel: (571)-260-3889 E-mail: dwilliams@meamagazine.com
Web Master CB & Associates. Email ClarenceB@meamagazine.com
Search
Archives
Pages
  • About MEA
  • Home
  • MEA Events
  • MEA Resource Guide
  • Home
  • MEA Events
  • Business News
  • Financial News
  • International News
  • Companies To Watch
  • Government News
  • Auto Industry
  • About MEA
    • Testimonial
  • MEA Resource Guide
  • MEA Events

MEA Magazine 2016 all rights reserved